NRCAM and malignant colon neoplasm: In contrast, higher levels of NrCAM in tumorous tissue deriving from glioblastoma, pancreatic, and colon cancer as well as papillary thyroid carcinoma were associated with a poorer prognosis [14, 15, 28, 29].